Skip to main content
BIOMARIN PHARMACEUTICAL INC logo

BIOMARIN PHARMACEUTICAL INC — Investor Relations & Filings

Ticker · BMRN ISIN · US09061G1013 LEI · NSLL8ITTRR0J5HEMR848 US Manufacturing
Filings indexed 1,867 across all filing types
Latest filing 2026-05-05 Interim / Quarterly Rep…
Country US United States of America
Listing US BMRN

About BIOMARIN PHARMACEUTICAL INC

https://www.biomarin.com/

BioMarin Pharmaceutical Inc. is a global biotechnology company that develops and commercializes therapies for rare, life-threatening genetic diseases. The company focuses on translating genetic discoveries into new medicines, with a core expertise in enzyme replacement therapies (ERTs). Its portfolio includes eight marketed products for conditions such as achondroplasia, severe hemophilia A, and various lysosomal storage diseases. In addition to its commercialized treatments, BioMarin maintains a pipeline of investigational medicines in various stages of clinical and preclinical development, aiming to create first-in-class and best-in-class therapeutics.

Recent filings

Filing Released Lang Actions
10-Q - BIOMARIN PHARMACEUTICAL INC (0001048477) (Filer)
Interim / Quarterly Report
2026-05-05 English
8-K - BIOMARIN PHARMACEUTICAL INC (0001048477) (Filer)
Regulatory Filings
2026-05-04 English
8-K - BIOMARIN PHARMACEUTICAL INC (0001048477) (Filer)
Regulatory Filings
2026-04-27 English
8-K - BIOMARIN PHARMACEUTICAL INC (0001048477) (Filer)
Regulatory Filings
2026-04-23 English
ARS - BIOMARIN PHARMACEUTICAL INC (0001048477) (Filer)
Annual Report
2026-04-21 English
4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)
Director's Dealing
2026-03-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.